Skip to main content
. 2017 May 8;8(30):49757–49772. doi: 10.18632/oncotarget.17693

Table 2. Baseline clinical characteristics of DLBCL patients with different IRF8 expression.

Variable IRF8 in tumor tissues
Low (n=41) High (n=26)
Age (years)
 <50 15 10
 ≥50 26 16
P value 0.552
Gender
 Male 25 15
 Female 16 11
P value 0.485
Ann Arbor stagea
 I-II 11 7
 III-IV 30 19
P value 0.392
IPI scoreb
 1-3 28 19
 4-5 13 7
P value 0.241

aAnn Arbor stage according to Ann Arbor-Cotswald stage (1989).

bIPI score, International Prognostic Index score.